These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19634713)

  • 21. Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis.
    Parikh R; Dalwadi S; Aboti P; Patel L
    J Antibiot (Tokyo); 2014 May; 67(5):387-94. PubMed ID: 24569669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
    Sharma R; Saxena D; Dwivedi AK; Misra A
    Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.
    Alves AD; Cavaco JS; Guerreiro F; Lourenço JP; Rosa da Costa AM; Grenha A
    Molecules; 2016 May; 21(6):. PubMed ID: 27240337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.
    Gaspar DP; Faria V; Gonçalves LM; Taboada P; Remuñán-López C; Almeida AJ
    Int J Pharm; 2016 Jan; 497(1-2):199-209. PubMed ID: 26656946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems.
    Verma RK; Singh AK; Mohan M; Agrawal AK; Misra A
    Ther Deliv; 2011 Jun; 2(6):753-68. PubMed ID: 22822507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages.
    Zhou H; Zhang Y; Biggs DL; Manning MC; Randolph TW; Christians U; Hybertson BM; Ng KY
    J Control Release; 2005 Oct; 107(2):288-99. PubMed ID: 16009444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.
    Omar SM; Maziad NA; El-Tantawy NM
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):78-87. PubMed ID: 30526251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis.
    Gaspar MM; Cruz A; Penha AF; Reymão J; Sousa AC; Eleutério CV; Domingues SA; Fraga AG; Filho AL; Cruz ME; Pedrosa J
    Int J Antimicrob Agents; 2008 Jan; 31(1):37-45. PubMed ID: 18006283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
    Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
    J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquine enhances the antimycobacterial activity of isoniazid and pyrazinamide by reversing inflammation-induced macrophage efflux.
    Matt U; Selchow P; Dal Molin M; Strommer S; Sharif O; Schilcher K; Andreoni F; Stenzinger A; Zinkernagel AS; Zeitlinger M; Sander P; Nemeth J
    Int J Antimicrob Agents; 2017 Jul; 50(1):55-62. PubMed ID: 28506804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifabutin loaded inhalable β-glucan microparticle based drug delivery system for pulmonary TB.
    Ahmad F; Ahmad S; Upadhyay TK; Singh S; Khubaib M; Singh J; Saeed M; Ahmad I; Al-Keridis LA; Sharma R
    Sci Rep; 2024 Jul; 14(1):16437. PubMed ID: 39013991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nano-Rifabutin entrapment within glucan microparticles enhances protection against intracellular Mycobacterium tuberculosis.
    Upadhyay TK; Fatima N; Sharma A; Sharma D; Sharma R
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):427-435. PubMed ID: 30672352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of macrophage apoptosis by antimycobacterial therapy: physiological role of apoptosis in the control of Mycobacterium tuberculosis.
    Gil D; Garcia LF; Rojas M
    Toxicol Appl Pharmacol; 2003 Jul; 190(2):111-9. PubMed ID: 12878041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.
    Kisich KO; Gelperina S; Higgins MP; Wilson S; Shipulo E; Oganesyan E; Heifets L
    Int J Pharm; 2007 Dec; 345(1-2):154-62. PubMed ID: 17624699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
    Holland DP; Hamilton CD; Weintrob AC; Engemann JJ; Fortenberry ER; Peloquin CA; Stout JE
    Pharmacotherapy; 2009 May; 29(5):503-10. PubMed ID: 19397460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages.
    Rodrigues S; Cunha L; Rico J; Rosa da Costa AM; Almeida AJ; Faleiro ML; Buttini F; Grenha A
    Drug Deliv Transl Res; 2020 Dec; 10(6):1675-1687. PubMed ID: 32562253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis.
    Jabès D; Della Bruna C; Rossi R; Olliaro P
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2346-50. PubMed ID: 7840568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage.
    Nair S; Ramaswamy PA; Ghosh S; Joshi DC; Pathak N; Siddiqui I; Sharma P; Hasnain SE; Mande SC; Mukhopadhyay S
    J Immunol; 2009 Nov; 183(10):6269-81. PubMed ID: 19880448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis.
    Chimote G; Banerjee R
    J Biomed Mater Res A; 2009 May; 89(2):281-92. PubMed ID: 18431766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.